GangaGen
Latest round
- Series E
Last raised
- Nov 2008
Total raised
- $5.4M
Investors
- 3
About GangaGen
GangaGen Inc.Founded in Palo Alto, US, GangaGen Inc. specializes in developing therapies targeting bacterial infections, particularly pneumonia caused by Klebsiella pneumoniae., Ltd. It operates without any known subsidiaries or parent companies, and there are no documented pivots in its business strategy.GangaGen is focused on developing novel treatments for drug-resistant bacterial infections, specifically targeting multidrug-resistant bacteria. Its core product, Klebicin, addresses pneumonia caused by Klebsiella pneumoniae, offering solutions for patients unresponsive to conventional treatments.GangaGen generates revenue through strategic partnerships and collaborations aimed at advancing its research programs, notably for Klebicin. Revenue is derived from agreements with healthcare providers and pharmaceutical companies, which may include licensing agreements or milestone payments linked to specific development phases. The company aims to strengthen its market presence in North America and Europe while considering potential expansions into other regions affected by antibiotic-resistant infections by the end of 2009.
Who invested in GangaGen
3 investors across 1 round
See all investors in GangaGen
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Nov 24, 2008
Amount
$5.4M
Investors
Questions about GangaGen
Who invested in GangaGen?
GangaGen has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GangaGen raised?
GangaGen has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did GangaGen last raise money?
GangaGen's most recent round on record is a Series E, in Nov 2008.
What does GangaGen do?
GangaGen is a biotechnology company.
Where is GangaGen headquartered?
GangaGen is headquartered in Palo Alto, US.
Which VCs invest in companies like GangaGen?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at GangaGen's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like GangaGen? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.